Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

SONAR Committees and Investigators

Research output: Contribution to journalArticlepeer-review

127 Scopus citations

Fingerprint

Dive into the research topics of 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences